Kumaresan Parthasarathi

Title: Innovator Spotlight: Kumaresan Parthasarathi

Introduction

Kumaresan Parthasarathi is an accomplished inventor based in Dayton, NJ, USA. With a total of four patents to his name, he has made significant contributions to the field of ophthalmology. His work primarily focuses on developing innovative pharmaceutical compositions that improve patient care and outcomes.

Latest Patents

One of his notable inventions is titled "Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof." This invention presents novel compositions consisting of an anti-inflammatory agent and a mydriatic agent specifically designed for intraocular use. The uniquely formulated compositions—containing ketorolac or its pharmaceutical salts and phenylephrine or its pharmaceutical salts—are free of buffering agents while maintaining stability for at least three months. Furthermore, this invention includes processes for preparing such compositions, making it a valuable addition to ophthalmological procedures, particularly when used in conjunction with intraocular irrigation solutions.

Another prominent patent by Kumaresan is "Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof." Similar to his previous work, this invention focuses on a composition comprising ketorolac and phenylephrine, highlighting the stability and effectiveness of these formulations without the use of buffering agents. This innovation aims to enhance the efficacy of ophthalmic treatments and patient experience.

Career Highlights

Kumaresan currently holds a key position at Somerset Therapeutics LLC, where he applies his expertise in pharmaceutical development and innovation. His contributions have significantly advanced the company's goals in providing effective pharmaceutical solutions for eye care.

Collaborations

Throughout his career, Kumaresan has collaborated with notable colleagues, including Mandar V Shah and Ilango Subramanian. These collaborative efforts have led to the successful development of numerous innovative products that address the needs of the ophthalmology sector.

Conclusion

Kumaresan Parthasarathi stands out as a dedicated inventor in the field of ophthalmology. His latest patents highlight his commitment to advancing medical technology, particularly through the development of stable and effective ocular compositions. As he continues to work with Somerset Therapeutics LLC and collaborate with other professionals, his contributions are likely to make a lasting impact on the industry and improve patient care worldwide.